Cell Membrane Capsules for Encapsulation of Chemotherapeutic and Cancer Cell Targeting in Vivo

作者: Li-Hua Peng , Yuan-Hong Zhang , Li-Jie Han , Chen-Zhen Zhang , Jia-He Wu

DOI: 10.1021/ACSAMI.5B05065

关键词:

摘要: Systemic administration of chemotherapeutic agents can cause indiscriminate drug distribution and severe toxicity. Until now, encapsulation targeting drugs have typically relied on synthetic vehicles, which cannot minimize the clearance by renal system may also increase risk chemical side effects. Cell membrane capsules (CMCs) provide a generic far more natural approach to challenges delivery in vivo. Here aptamer AS1411, recognize bind overexpressed nucleolin cancer cell membrane, was chemically conjugated onto CMCs. As result, AS1411 modified CMCs showed enhanced ingestion certain cells vitro accumulation mouse xenografts Chemotherapeutics contrast with therapeutically significant concentrations be packaged into reversible permeating their plasma membranes. The systematic loaded doxorubicin hydrochloride significantly inh...

参考文章(41)
Langer R, Drug delivery and targeting Nature. ,vol. 392, pp. 5- 10 ,(1998)
Dahai Yu, Yuying Zhang, Zhengwei Mao, Changyou Gao, Study of the selective uptake progress of aptamer-modified PLGA particles by liver cells. Macromolecular Bioscience. ,vol. 13, pp. 1413- 1421 ,(2013) , 10.1002/MABI.201300165
Tadanori Mayumi, Naoki Okada, Shinsaku Nakagawa, Jian-Qing Gao, Yusuke Eto, Yasuo Yoshioka, Fumiko Sekiguchi, Shinnosuke Kurachi, Tomohiro Morishige, Xinglei Yao, Hikaru Watanabe, Ratima Asavatanabodee, Fuminori Sakurai, Hiroyuki Mizuguchi, Yuka Okada, Yohei Mukai, Yasuo Tsutsumi, Effective tumor targeted gene transfer using PEGylated adenovirus vector via systemic administration Journal of Controlled Release. ,vol. 122, pp. 102- 110 ,(2007) , 10.1016/J.JCONREL.2007.06.010
I. Walev, S. C. Bhakdi, F. Hofmann, N. Djonder, A. Valeva, K. Aktories, S. Bhakdi, Delivery of proteins into living cells by reversible membrane permeabilization with streptolysin-O. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 98, pp. 3185- 3190 ,(2001) , 10.1073/PNAS.051429498
Hon-Jian Wei, Alexander TH Wu, Chung-Huei Hsu, Yi-Ping Lin, Wen-Fang Cheng, Ching-Hua Su, Wen-Ta Chiu, Jacqueline Whang-Peng, Frank L Douglas, Win-Ping Deng, The Development of a Novel Cancer Immunotherapeutic Platform Using Tumor-targeting Mesenchymal Stem Cells and a Protein Vaccine Molecular Therapy. ,vol. 19, pp. 2249- 2257 ,(2011) , 10.1038/MT.2011.152
Raghavendra C Mundargi, V Ramesh Babu, Vidhya Rangaswamy, Pradip Patel, Tejraj M Aminabhavi, None, Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives. Journal of Controlled Release. ,vol. 125, pp. 193- 209 ,(2008) , 10.1016/J.JCONREL.2007.09.013
Todd E. Meyerrose, Daniel A. De Ugarte, A. Alex Hofling, Phillip E. Herrbrich, Taylor D. Cordonnier, Leonard D. Shultz, J. Chris Eagon, Louisa Wirthlin, Mark S. Sands, Marc A. Hedrick, Jan A. Nolta, In vivo distribution of human adipose-derived mesenchymal stem cells in novel xenotransplantation models. Stem Cells. ,vol. 25, pp. 220- 227 ,(2007) , 10.1634/STEMCELLS.2006-0243
Alessandro Parodi, Nicoletta Quattrocchi, Anne L. van de Ven, Ciro Chiappini, Michael Evangelopoulos, Jonathan O. Martinez, Brandon S. Brown, Sm Z. Khaled, Iman K. Yazdi, Maria Vittoria Enzo, Lucas Isenhart, Mauro Ferrari, Ennio Tasciotti, Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functions Nature Nanotechnology. ,vol. 8, pp. 61- 68 ,(2013) , 10.1038/NNANO.2012.212
Jennifer A MacDiarmid, Nancy B Amaro-Mugridge, Jocelyn Madrid-Weiss, Ilya Sedliarou, Stefanie Wetzel, Kartini Kochar, Vatsala N Brahmbhatt, Leo Phillips, Scott T Pattison, Carlotta Petti, Bruce Stillman, Robert M Graham, Himanshu Brahmbhatt, Sequential treatment of drug-resistant tumors with targeted minicells containing siRNA or a cytotoxic drug Nature Biotechnology. ,vol. 27, pp. 643- 651 ,(2009) , 10.1038/NBT.1547